Fig. 1From: A randomized placebo-controlled phase I clinical trial to evaluate the immunomodulatory activities of Atractylodes lancea (Thunb) DC. in healthy Thai subjectsFold-changes of IL17A, IFNγ, TNFα, IL2, IL4, IL6, and IL10 compared with baseline levels in healthy Thai subjects following the administration of a single oral dose of 1000 mg of standardized AL extract (n = 20) and placebo (n = 4). Data are presented as median (range) valuesBack to article page